Reich, K., Zschocke, I., Bachelez, H., de Jong, E., Gisondi, P., Puig, L., . . . Mrowietz, U. (2017). A Topical Treatment Optimization Programme (TTOP) improves clinical outcome for calcipotriol/ betamethasone gel in psoriasis: Results of a 64-week multinational randomized phase IV study in 1790 patients (PSO-TOP).
Citación estilo ChicagoReich, K., I. Zschocke, H. Bachelez, EMGJ de Jong, P. Gisondi, L. Puig, RB Warren, C. Ortland, y U. Mrowietz. A Topical Treatment Optimization Programme (TTOP) Improves Clinical Outcome for Calcipotriol/ Betamethasone Gel in Psoriasis: Results of a 64-week Multinational Randomized Phase IV Study in 1790 Patients (PSO-TOP). 2017.
Cita MLAReich, K., et al. A Topical Treatment Optimization Programme (TTOP) Improves Clinical Outcome for Calcipotriol/ Betamethasone Gel in Psoriasis: Results of a 64-week Multinational Randomized Phase IV Study in 1790 Patients (PSO-TOP). 2017.